Amylin and Alkermes shine in drug-stocks trading By: MarketWatch July 08, 2011 at 10:58 AM EDT Amylin and Alkermes shine in early drug-stock trading Friday, fueled by positive news about their diabetes drug candidate Bydureon. Read More >> Related Stocks: Eli Lilly Johnson & Johnson Merck & Co Pfizer